POLYSERP

New York, United States Founded: 2020 • Age: 6 yrs
Develops shelf-stable antivenoms for snake bites, targeting medical providers in remote regions.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About POLYSERP

POLYSERP is a company based in New York (United States) founded in 2020. It operates as a B2B. POLYSERP offers products and services including POLYSERP PAN-AFRICA and POLYSERP MENA. POLYSERP operates in a competitive market with competitors including Beijing Kangchen Pharmaceutical, Ophirex, Vins Bio Products, Mediclone Biotech and Albila, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of POLYSERP

POLYSERP offers a comprehensive portfolio of products and services, including POLYSERP PAN-AFRICA and POLYSERP MENA.

Product name locked
Category locked
Primary

Treats envenomations from African snake species in austere environments.

Product name locked
Category locked
Locked

Addresses snake bites in the Middle East and North Africa with broad coverage.

Funding Insights of POLYSERP

Premium access

Detailed funding history for POLYSERP

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by POLYSERP

Investments
Premium access

Investment portfolio details for POLYSERP

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - POLYSERP

Premium access

Detailed financials for POLYSERP

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Polyserp Comparisons

POLYSERP Primary company
Description
Develops shelf-stable antivenoms for snake bites, targeting ...
Location
New York, United States
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for POLYSERP

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of POLYSERP

POLYSERP operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Kangchen Pharmaceutical, Ophirex, Vins Bio Products, Mediclone Biotech and Albila, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Antivenom drugs and pharmaceutical products are developed and manufactured.
Locked Locked Locked
Oral therapies for snake bite treatment are developed.
Locked Locked Locked
Antisera and antitoxins for snake bites and infections are developed.
Locked Locked Locked
Diagnostic kits and therapeutic biologics are manufactured and developed.
Locked Locked Locked
Horse-derived antidotes for animal stings are developed.
Locked Locked Locked
Antiven creates innovative vaccines for snake bite treatment using biotechnology and proteomics.
Premium access

Detailed competitors of POLYSERP

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Polyserp

Premium access

Complete news archive for POLYSERP

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about POLYSERP

POLYSERP was founded in 2020.

POLYSERP is headquartered in New York, United States. It is registered at New York, New York, United States.

POLYSERP produces broad-spectrum, freeze-dried antivenoms designed for use in harsh, unrefrigerated conditions, covering regions like Africa, the Middle East, and Central Asia. They offer products such as POLYSERP PAN-AFRICA and POLYSERP MENA, which treat envenomations from various snake species without needing species identification. Based in New York, United States, the company focuses on safe administration for medical providers, emphasizing affordability, efficacy, and ease of use in low-resource settings.

POLYSERP's top competitors include Ophirex, Beijing Kangchen Pharmaceutical and Vins Bio Products.

POLYSERP offers POLYSERP PAN-AFRICA and POLYSERP MENA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available